ISSN:

Journal Home

Trials Q2 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Trials is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology (medical) with an H index of 103. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1890 €. The scope of the journal is focused on trial methodology, trial protocols, randomised controlled trials, medical trials. It has an SJR impact factor of 0,893 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,893.

Trials focuses its scope in these topics and keywords: controlled, randomized, protocol, study, randomised, trial, trials, therapy, clinical, intervention, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Pharmacology (medical) (Q2)

Price

1890 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,893

SJR Impact factor

103

H Index

832

Total Docs (Last Year)

2750

Total Docs (3 years)

32225

Total Refs

5818

Total Cites (3 years)

2612

Citable Docs (3 years)

2

Cites/Doc (2 years)

38.73

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical and Translational Oncology Q2
Neuro-Oncology Practice Q2
Revista de Saude Publica Q2
Human Vaccines and Immunotherapeutics Q2
British Journal of Nutrition Q2

Compare this journals